Rasio Therapeutics

Baltimore, United States

Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.

$1.5M raised

Nov 2021

Seed

Biopharma Biotechnology Health Care Life Science Pharmaceutical

Top Investors

National Foundation for Cancer Research

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rasio Therapeutics

How much funding has Rasio Therapeutics raised?

Rasio Therapeutics has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in November 2021.

Who are Rasio Therapeutics's investors?

Rasio Therapeutics's investors include National Foundation for Cancer Research.

Where is Rasio Therapeutics headquartered?

Rasio Therapeutics is headquartered in Baltimore, United States.

What does Rasio Therapeutics do?

Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.

What stage is Rasio Therapeutics at?

Rasio Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 26, 2021.

MLA

"Rasio Therapeutics — Funding & Investors." VCBacked, November 26, 2021, https://www.vcbacked.co/company/rasio-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2021). Rasio Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/rasio-therapeutics

Wikipedia (cite web)

{{cite web |title=Rasio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rasio-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 26, 2021.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.